Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 09-2018 | 06-2018 | |
| Operating Expenses | 0 | 2,473 | 2,431 |
| Operating Income | N/A | -2,473 | -2,431 |
| Interest Expense | 0 | -192 | 307 |
| Other Income | 0 | -3,957 | 2,199 |
| Pre-tax Income | 0 | -6,238 | -539 |
| Net Income Continuous | N/A | -6,238 | -539 |
| Net Income | $N/A | $-6,238 | $-539 |
| EPS Basic Total Ops | N/A | -1,247,600.00 | N/A |
| EPS Basic Continuous Ops | N/A | -1,247,600.00 | N/A |
| EPS Diluted Total Ops | N/A | -1,247,600.00 | N/A |
| EPS Diluted Continuous Ops | N/A | -1,247,600.00 | N/A |
| EBITDA(a) | $N/A | $-1,149 | $-2,431 |